Fig. 2.
Main characteristics of the included studies. VKA vitamin K antagonist, NOAC non-VKA oral anticoagulant, OAC oral anticoagulant, AF atrial fibrillation, NA not applicable, DCE discrete choice experiment
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.